Blonder Tongue Laboratories, Inc.

Total Valuation

Blonder Tongue Laboratories, Inc. carries a market capitalization of 1,447.00, placing it among publicly traded companies globally. Its enterprise value stands at 9.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Blonder Tongue Laboratories, Inc. currently has 14.47M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.12, and the price-to-book ratio stands at -0.04.

Enterprise Valuation

On an enterprise value basis, Blonder Tongue Laboratories, Inc. trades at an EV/EBITDA multiple of 44.19 and an EV/FCF ratio of 3.79.

Financial Position

Blonder Tongue Laboratories, Inc. maintains a current ratio of 0.72, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,030.45, indicating conservative leverage, while an interest coverage ratio of 0.26 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Blonder Tongue Laboratories, Inc.'s stock has declined approximately -99.54545% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

Income Statement

Over the trailing twelve months, Blonder Tongue Laboratories, Inc. generated 11.66M in revenue and converted that into -1.22M in net income, yielding earnings per share of -0.08. EBITDA reached 218,000.00, while operating income came in at -660,000.00.

Balance Sheet

Blonder Tongue Laboratories, Inc. holds 71,000.00 in cash and equivalents against 8.33M in total debt, resulting in a net debt position of 4.48M. Total book value stands at -32.67M, with working capital of -1.76M providing operational flexibility.

Cash Flow

Blonder Tongue Laboratories, Inc. produced 1.67M in operating cash flow over the past twelve months. After subtracting -15,000.00 in capital expenditures, free cash flow totaled 1.65M - equivalent to 0.11 per share.

Margins

Blonder Tongue Laboratories, Inc. operates with a gross margin of 31.21, reflecting its pricing power and cost economics. The operating margin of -5.66 and net profit margin of -10.49 provide insight into operational efficiency.

Dividends & Yields

Scores

Blonder Tongue Laboratories, Inc. posts an Altman Z-Score of -4.00, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.